Skip to main content

Advertisement

Table 3 Reasons for negative reimbursement recommendations for DURDs and DORDs

From: Characteristics of drugs for ultra-rare diseases versus drugs for other rare diseases in HTA submissions made to the CADTH CDR

Reason DURDs N = 9 DORDs N = 13
Clinical only, n (%) 8 (88.9) 8 (61.5)
Cost only, n (%) 1 (11.1) 1 (7.7)
Clinical and cost, n (%) 0 (0) 4 (30.8)